NR3C2 Inhibits the Proliferation of Colorectal Cancer via Regulating Glucose Metabolism and Phosphorylating AMPK

Scientists investigated the roles and mechanisms of NR3C2 in colorectal cancer (CRC). The expression of NR3C2 in CRC tumors and paired paracancerous tissues of 71 CRC patients and five CRC cell lines was detected by western blotting, immunohistochemistry, and real-time reverse-transcription PCR.